Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghav Sundar

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
NPJ Precision Oncology|February 21, 2025
Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trialAgata Blasiak, Anh T L Truong, Nigel Foo, et al.
Liver Cancer|September 26, 2022
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical TrialStephen Lam Chan, Chanisa Chotipanich, Su Pin Choo, et al.
Health and Quality of Life Outcomes|July 25, 2020
Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapyHui Lin Cheng, Violeta Lopez, Simon Ching Lam, et al.
Cancer Research|February 9, 2021
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer ChemotherapyOmer An, Yangyang Song, Xinyu Ke, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2018
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trialsRaghav Sundar, Terri McVeigh, David Dolling, et al.
BMC Cancer|November 18, 2020
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursYvonne L E Ang, Gwo Fuang Ho, Ross A Soo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 8, 2019
Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathyAishwarya Bandla, Stacey Tan, Nesaretnam Barr Kumarakulasinghe, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 18, 2020
Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine modelHon Lyn Tan, Guowei Kim, Christopher John Charles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2019
Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapyFiona Yeo, Chiu Chin Ng, Kiley W J Loh, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
NPJ Precision Oncology|February 21, 2025
Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trialAgata Blasiak, Anh T L Truong, Nigel Foo, et al.
Liver Cancer|September 26, 2022
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical TrialStephen Lam Chan, Chanisa Chotipanich, Su Pin Choo, et al.
Health and Quality of Life Outcomes|July 25, 2020
Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapyHui Lin Cheng, Violeta Lopez, Simon Ching Lam, et al.
Cancer Research|February 9, 2021
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer ChemotherapyOmer An, Yangyang Song, Xinyu Ke, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2018
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trialsRaghav Sundar, Terri McVeigh, David Dolling, et al.
BMC Cancer|November 18, 2020
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursYvonne L E Ang, Gwo Fuang Ho, Ross A Soo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 8, 2019
Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathyAishwarya Bandla, Stacey Tan, Nesaretnam Barr Kumarakulasinghe, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2023
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidinesJoline S J Lim, Samuel G W Ow, Andrea L A Wong, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 18, 2020
Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine modelHon Lyn Tan, Guowei Kim, Christopher John Charles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2019
Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapyFiona Yeo, Chiu Chin Ng, Kiley W J Loh, et al.
Pageof 15